RE:RE:Corporate Presentation August 31More on Vivo in an article at the link below:
https://equity.guru/2018/09/04/canopy-growth-corp-weed-t-5-billion-buy-something-whats-list/ "But back to Vivo – they have a retail storefront strategy, and skin in the game rather than just talk, which makes them an ever tastier option.
This is Harvest Medicine, which they acquired and are rapidly building out.
- Education focused, patient-centric, cannabis discovery center and clinic
- Acquiring over 1,300 new patients monthly from a single location
- One of Canada’s most successful and fastest growing cannabis clinics
- Expand the highly-rated and scalable initial location to add over 15,000 active patients per year
Vivo also has a deal with Choom, which we mentioned earlier.
Lastly, in the spring, Vivo had a cash balance of $130m, which means not only are they able to scale up fast, but over a third of their $338m market cap comes in cash on hand."
Risk reduced, potential for surges in value not unlikely.